Key facts
- This page summarizes Barry H. Dash's Form 4 filing for ELITE PHARMACEUTICALS INC /NV/ (ELTP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Oct 2026, 06:05.
Barry H. Dash - 09 Oct 2026 Form 4 Insider Report for ELITE PHARMACEUTICALS INC /NV/ (ELTP)
- Reporting relationship
- Director
- Issuer ticker
- ELTP
- Reported as of
- 09 Oct 2026
- Net transaction value
- +$25,980
- SEC form
- 4
- Accepted by SEC
- 19 Oct 2026, 06:05:37 UTC
- Prior SEC filing
- 10 Sep 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Barry Dash
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Barry H. Dash filed Form 4 for ELITE PHARMACEUTICALS INC /NV/ (ELTP) on 19 Oct 2026.
Change
- Previous filing in this sequence was filed on 10 Sep 2026.
- Current net transaction value: +$25,980.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001324222
Primary reporting owner
Dash Barry H
- Relationship
- Director
- Address
- C/O ELITE PHARMACEUTICALS, INC., 165 LUDLOW AVE, NORTHVALE
- Signature
- /s/ Barry Dash
- Signature date
- 19 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELTP
transaction
Common Stock
Purchase
- Transaction value
- $25,980
- Shares
- +100,000
- Change %
- +3.1%
- Price
- $0.2598
- Shares after
- 3,365,555
- Date
- 09 Oct 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.